News|Videos|November 2, 2023

Making Visual Inspection Accessible with Luo Automation at CPHI Barcelona

Pharmaceutical Technology Europe® spoke with Joren van der Horst from Luo Automation, a Dutch company focused on automated visual inspection solutions, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Visual inspection is an integral process in the production of filled and sealed pharmaceutical products to ensure there are no particles or contaminants in the finished parenteral dosage form. Currently, both manual and automated processes are used for visual inspection; however, automated systems can be expensive to implement and not always accessible for smaller companies dealing with smaller batch sizes.

Accessibility of automated visual inspection solutions is a key focus for Luo Automation, a Dutch company researching, developing, and producing automated visual inspection machines. To learn more about the company and how it is making visual inspection more accessible, Pharmaceutical Technology Europe® spoke with the company’s founder, Joren van der Horst, at CPHI Barcelona 2023.

Visual inspection solutions

"We make visual inspection [solutions] for very small batches,” explained Horst. As with all visual inspection technologies, the primary aim is to check the quality of the medicine and make sure there are no foreign particles or contaminants present, he added.

To perform the inspection, the finished dosage form—syringes, ampoules, and vials—are swirled and then any movement of particles within can be detected, Horst continued. “Another cool thing is the [current interest] in artificial intelligence and machine learning,” he said. “We use machine learning algorithms that are pretty new to also detect static defects. So, not only particles but also leakages and such.”

Focus on the small scale

For Horst, a major differentiator for Luo Automation within industry is the focus on smaller-scale inspection. “If you want, you can buy a huge inspection machine that will cost you a couple of million, but then you need to produce 100 million containers per year,” he stressed. “But, if you have clinical trials or personalized medicine, you cannot [perform the inspection] with a huge machine.”

Luo Automation was featured at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023. CPHI Barcelona ran from Oct. 24–26, 2023.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Ask the Expert: Choosing Ingredient Suppliers
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.